PT-141
$149.00
PT-141 (also known as Bremelanotide) is a synthetic peptide derived from the melanocortin family, originally developed from Melanotan II. Unlike traditional sexual enhancement drugs that target the vascular system, PT-141 works on the central nervous system to stimulate sexual desire and arousal in both men and women. It is FDA-approved for certain female sexual dysfunction indications but is also widely researched off-label for libido enhancement.
Potential Benefits (Based on Existing Research)
PT-141 has been studied for its potential to:
- Increase sexual desire and arousal in both men and women
- Support treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women
- Help with erectile dysfunction in men, especially in cases unresponsive to PDE5 inhibitors
- Act rapidly without relying on direct blood flow mechanisms
- Enhance mood and intimacy through melanocortin system stimulation
Note: PT-141 is FDA-approved for specific uses in women. Other applications are investigational and off-label.
Description
Mechanism of Action
PT-141 works by:
- Binding to melanocortin receptors (MC3R and MC4R) in the brain
- Stimulating sexual arousal centers in the hypothalamus, unlike PDE5 inhibitors which affect blood vessels
- Promoting neurogenic arousal, impacting desire and intimacy through the central nervous system
Potential Side Effects / Considerations
- Nausea (most common side effect, dose-dependent)
- Flushing, headache, or temporary increase in blood pressure
- Possible darkening of moles or pigmentation changes (in rare cases)
- Use with caution in individuals with cardiovascular risk
- Should not be combined with other melanocortin agonists without clinical guidance
Note: PT-141 is FDA-approved for specific uses in women. Other applications are investigational and off-label.
Additional information
| Clinical Information | • Full Name: Bremelanotide (PT-141) |
|---|---|
| Size | 30mL |
You must be logged in to post a review.
Reviews
There are no reviews yet.